![JACC Specialty Journals artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/d7/86/14/d7861461-41ca-e6ee-7c5d-856f80bce63f/mza_4499502022160196253.jpg/100x100bb.jpg)
JACC: CardioOncology Pulse - Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy
JACC Specialty Journals
English - April 23, 2024 18:00 - 13 minutes - 30.5 MB - ★★★★ - 18 ratingsMedicine Health & Fitness Science Life Sciences arrhythmias atrialfibrillation cardiology electrophysiology heartrhythm hospital medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.